Beacon Equity Research Featured Company: National Pharmaceuticals Corp. (NFRM)
National Pharmaceuticals Corp. is a pharmaceutical research and development company dedicated to leading edge technologies for treatment of human diseases. The company has focused its efforts on the business of licensing mid stage development drugs for further development and marketing worldwide. The company’s lead therapeutic drug is believed to have significant effects on the management of pain due to trauma, wound, and accidents, as well as autoimmune conditions. Under the internal name GLB333, the cytokine functions differently than current pain killers or analgesics. It helps to rebuild the damage tissues, reduces inflammatory conditions and helps to regenerate good and healthy…